We recently published a list of 10 Most Profitable Value Stocks to Buy Now. In this article, we are going to take a look at ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

We recently published a list of 10 Most Undervalued S&P 500 Stocks to Buy Now. In this article, we are going to take a look ...

Lane. Pfizer has deemed the property surplus and has offered to sell it to the city for $1.00. It is recommended that City ...

Pfizer has exited Haleon through four block trades, the most recent of which was its sale of a 7.7% stake in January at a 2.75% discount. GSK sold its last shares in the company last year. Also on ...

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total pay increase, according (PDF) to a securities filing.

That said, Pfizer has also started to “milk” its oncology portfolio following the full year from its Seagen acquisition since late 2023. $43B is a huge sum to pay and has also loaded the ...

ADCs have gained prominence in oncology, with numerous pharmaceutical companies pursuing collaborations and acquisitions to bolster their pipelines with the promising modality. Pfizer’s ...

Pfizer is going "all in" to develop its experimental ... has faced criticism from activist investor Starboard Value over its big acquisitions, as well as its disappointing internal research ...

Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

At the beginning of May, Pfizer spun back out Esperion Therapeutics, which it had originally purchased for $1.3 billion in March 2004. Since the acquisition, most of Esperion's promising pipeline ...